Grey Area Labs’ longevity coverage delivers research-backed analysis on the science of extending human healthspan. From supplement deep-dives and peptide protocols to senolytic therapies and clinical trial breakdowns, every article is grounded in peer-reviewed evidence.
Whether you’re a biohacker optimizing your own protocol or a researcher tracking the latest aging science, you’ll find comprehensive guides, head-to-head comparisons, and honest assessments of what the evidence actually shows — not what supplement companies want you to believe.
What We Cover
Longevity Molecules: NMN, NR, rapamycin, metformin, fisetin, urolithin A, resveratrol, spermidine, and emerging compounds in clinical trials.
Peptides & Therapeutics: BPC-157, TB-500, epithalon, GHK-Cu, and research peptides with longevity applications.
Aging Research: Senolytics, epigenetic reprogramming, caloric restriction mimetics, NAD+ metabolism, and the biology of aging.
Protocols & Comparisons: Evidence-based supplement comparisons, dosing guides, and biomarker tracking.
Subscribe to Accelerated for weekly longevity research highlights delivered to your inbox.
Disclaimer: All content is for informational purposes only and is not medical advice. Consult a healthcare provider before starting any supplement or peptide protocol.
Stay Ahead with Accelerated
Weekly insights at the intersection of longevity science, AI, and emerging technology. Written by Ryan Bethencourt.
Subscribe to Accelerated